Physician profile
John A Appiott
NPI 1669440681
$1,620.31
in general payments reported to CMS, 2019-2025
18 companies · $259 in 2025
The $259 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $137 · 2021: $48.69 · 2022: $190 · 2023: $264 · 2024: $328 · 2025: $259.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $851.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $850.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $214.29 | 2019-2025 | |
| Novo Nordisk INC | $192.35 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $166.62 | 2019-2025 | Farxiga |
| Lilly USA, LLC | $160.81 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Astellas Pharma US INC | $132.42 | 2019-2024 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $113.16 | 2019-2022 | |
| Otsuka America Pharmaceutical, INC. | $107.81 | 2022-2024 | Rexulti |
| Exact Sciences Corporation | $107.60 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Sunovion Pharmaceuticals INC. | $105.75 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $82.69 | 2022-2025 | |
| Janssen Pharmaceuticals, INC | $54.89 | 2019-2021 | |
| Amgen INC. | $39.44 | 2022-2025 | Krystexxa |
| Glaxosmithkline, LLC. | $36.27 | 2022-2023 | Shingrix, Arexvy |
| Merck Sharp & Dohme LLC | $29.32 | 2019-2025 | Gardasil 9, Capvaxive |
| Dexcom, INC. | $25.00 | 2024 | Dexcom G6 Transmitter |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $23.85 | 2019 | |
| Abbvie INC. | $14.30 | 2022 | |
| Medtronic Vascular, INC. | $13.74 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Appiott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.